BackgroundCheck.run
Search For

Radha S Narayan, 4922 Thomas St, Belmont, MA 02478

Known as:
Radha S Deshpande Radha Ravi Deshpande Radha R Deshpande
Related to:
Sushila Narayan

Radha Narayan Phones & Addresses

22 Thomas St, Belmont, MA 02478    617-9933163   

Cambridge, MA   

320 School St, Watertown, MA 02472   

La Jolla, CA   

Burlington, MA   

Wilmington, MA   

East Lansing, MI   

Howell, MI   

22 Thomas St, Belmont, MA 02478   

Get Report
Control this profile

Mentions for Radha S Narayan

Radha Narayan resumes & CV records

Resumes

Radha Narayan Photo 31

Global Medical Communications, Associate Director

Location:
Belmont, MA
Industry:
Pharmaceuticals
Work:
Alexion Pharmaceuticals, Inc.
Global Medical Communications, Associate Director Rias Medical Publications
Principal
Education:
Indian Institute of Technology, Bombay
Master of Science, Masters, Chemistry Michigan State University
Doctorates, Doctor of Philosophy, Organic Chemistry
Skills:
Medical Publications, Medical Communications, Medical Writing, Vendor Management, Strategic Planning, Strategic Communications, Scientific Communications, Drug Development, Medicinal Chemistry, Organic Synthesis, Biotechnology, Research, Chemistry, Drug Design, Lifesciences, Laboratory, Interdisciplinary Collaborations
Languages:
English
Marathi
Hindi
Certifications:
Ismpp Cmpp
License 2312
International Society For Medical Publication Professionals, License 2312
Radha Narayan Photo 32

Radha Narayan

Work:
The World Bank
Procurement Assistant
Radha Narayan Photo 33

Radha Narayan

Skills:
Collateral, Warehousing, Software, Agri
Radha Narayan Photo 34

Radha Narayan

Radha Narayan Photo 35

Radha Narayan

Radha Narayan Photo 36

Radha Narayan

Publications & IP owners

Us Patents

Pyridine, Bicyclic Pyridine And Related Analogs As Sirtuin Modulators

US Patent:
2011026, Oct 27, 2011
Filed:
Oct 29, 2009
Appl. No.:
13/125788
Inventors:
Radha Narayan - Cambridge MA, US
Jeremy S. Disch - Natick MA, US
Robert B. Perni - Marlborough MA, US
Chi B. Vu - Arlington MA, US
Assignee:
Sirtris Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 31/497
A61K 31/5377
A61K 31/506
A61K 31/47
A61K 31/444
A61K 31/4439
A61K 31/443
A61K 31/4418
C07D 413/14
C07D 491/052
C07D 413/06
C07D 401/12
C07D 215/48
C07D 417/12
C07D 401/06
C07D 405/12
C07D 213/56
A61P 5/50
A61P 3/00
A61P 3/10
A61K 31/4709
US Classification:
51421021, 5142338, 5142352, 5142355, 51425505, 514256, 514275, 514311, 514314, 514332, 514342, 514343, 514336, 514357, 544120, 544127, 544128, 544131, 544328, 544331, 544333, 544405, 546169, 546170, 546262, 5462697, 5462707, 5462764, 5462837, 546337
Abstract:
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Substituted Bicyclic Aza-Heterocycles And Analogues As Sirtuin Modulators

US Patent:
2018018, Jul 5, 2018
Filed:
Feb 26, 2018
Appl. No.:
15/904993
Inventors:
- Wilmington DE, US
Radha Narayan - Belmont MA, US
Christopher Oalmann - Watertown MA, US
Chi B. Vu - Arlington MA, US
International Classification:
C07D 487/04
A61K 45/06
C07D 495/10
A61K 31/519
C07D 491/107
A61K 31/5025
A61K 31/506
C07D 519/00
A61K 31/5377
A61K 31/56
Abstract:
Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Substituted Bicyclic Aza-Heterocycles And Analogues As Sirtuin Modulators

US Patent:
2014034, Nov 27, 2014
Filed:
Oct 19, 2012
Appl. No.:
14/353096
Inventors:
- Wilmington DE, US
Radha Narayan - Belmont MA, US
Christopher Oalmann - Watertown MA, US
Chi B. Vu - Arlington MA, US
International Classification:
C07D 487/04
C07D 495/10
C07D 491/107
A61K 31/519
A61K 31/5025
A61K 31/5377
US Classification:
51421021, 544236, 514248, 544117, 5142332, 544230, 544281, 5142593, 51425505, 435375
Abstract:
Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Possible Relatives

Deo Narayan  Dev Narayan  Dharmisthaben D Narayan  Hari Narayan  Joanne V Narayan  Karen E Narayan  Kaushik B Narayan  Radha R Nair  Radha G Pai  Radha Singh 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.